Innate Pharma Stock Technical Analysis
| IPHYF Stock | USD 2.15 0.00 0.00% |
As of the 12th of February 2026, Innate Pharma retains the Market Risk Adjusted Performance of (0.40), standard deviation of 1.63, and Risk Adjusted Performance of 0.0643. Innate Pharma technical analysis makes it possible for you to employ historical prices and volume momentum with the intention to determine a pattern that calculates the direction of the firm's future prices. Please check out Innate Pharma variance and kurtosis to decide if Innate Pharma is priced fairly, providing market reflects its last-minute price of 2.15 per share. Please also validate Innate Pharma information ratio, which is currently at 0.0113 to confirm the company can sustain itself at a future point.
Innate Pharma Momentum Analysis
Momentum indicators are widely used technical indicators which help to measure the pace at which the price of specific equity, such as Innate, fluctuates. Many momentum indicators also complement each other and can be helpful when the market is rising or falling as compared to InnateInnate |
Innate Pharma 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Innate Pharma's pink sheet what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Innate Pharma.
| 11/14/2025 |
| 02/12/2026 |
If you would invest 0.00 in Innate Pharma on November 14, 2025 and sell it all today you would earn a total of 0.00 from holding Innate Pharma or generate 0.0% return on investment in Innate Pharma over 90 days. Innate Pharma is related to or competes with NDT Pharmaceuticals, Molecular Partners, Scancell Holdings, Brii Biosciences, Ascend Wellness, JW (Cayman), and Hofseth BioCare. Innate Pharma S.A., a biotechnology company, discovers, develops, and commercializes therapeutic antibodies for the trea... More
Innate Pharma Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Innate Pharma's pink sheet current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Innate Pharma upside and downside potential and time the market with a certain degree of confidence.
| Information Ratio | 0.0113 | |||
| Maximum Drawdown | 12.57 |
Innate Pharma Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Innate Pharma's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Innate Pharma's standard deviation. In reality, there are many statistical measures that can use Innate Pharma historical prices to predict the future Innate Pharma's volatility.| Risk Adjusted Performance | 0.0643 | |||
| Jensen Alpha | 0.1375 | |||
| Total Risk Alpha | (0.08) | |||
| Treynor Ratio | (0.41) |
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Innate Pharma's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Innate Pharma February 12, 2026 Technical Indicators
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | 0.0643 | |||
| Market Risk Adjusted Performance | (0.40) | |||
| Mean Deviation | 0.3771 | |||
| Coefficient Of Variation | 1339.58 | |||
| Standard Deviation | 1.63 | |||
| Variance | 2.67 | |||
| Information Ratio | 0.0113 | |||
| Jensen Alpha | 0.1375 | |||
| Total Risk Alpha | (0.08) | |||
| Treynor Ratio | (0.41) | |||
| Maximum Drawdown | 12.57 | |||
| Skewness | 6.76 | |||
| Kurtosis | 54.45 |
Innate Pharma Backtested Returns
At this point, Innate Pharma is relatively risky. Innate Pharma holds Efficiency (Sharpe) Ratio of 0.0783, which attests that the entity had a 0.0783 % return per unit of risk over the last 3 months. We have found sixteen technical indicators for Innate Pharma, which you can use to evaluate the volatility of the firm. Please check out Innate Pharma's Standard Deviation of 1.63, risk adjusted performance of 0.0643, and Market Risk Adjusted Performance of (0.40) to validate if the risk estimate we provide is consistent with the expected return of 0.13%. Innate Pharma has a performance score of 6 on a scale of 0 to 100. The company retains a Market Volatility (i.e., Beta) of -0.27, which attests to not very significant fluctuations relative to the market. As returns on the market increase, returns on owning Innate Pharma are expected to decrease at a much lower rate. During the bear market, Innate Pharma is likely to outperform the market. Innate Pharma right now retains a risk of 1.71%. Please check out Innate Pharma variance and kurtosis , to decide if Innate Pharma will be following its current trending patterns.
Auto-correlation | 0.00 |
No correlation between past and present
Innate Pharma has no correlation between past and present. Overlapping area represents the amount of predictability between Innate Pharma time series from 14th of November 2025 to 29th of December 2025 and 29th of December 2025 to 12th of February 2026. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Innate Pharma price movement. The serial correlation of 0.0 indicates that just 0.0% of current Innate Pharma price fluctuation can be explain by its past prices.
| Correlation Coefficient | 0.0 | |
| Spearman Rank Test | 0.41 | |
| Residual Average | 0.0 | |
| Price Variance | 0.0 |
Innate Pharma technical pink sheet analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, pink sheet market cycles, or different charting patterns.
Innate Pharma Technical Analysis
The output start index for this execution was one with a total number of output elements of sixty. The Normalized Average True Range is used to analyze tradable apportunities for Innate Pharma across different markets.
About Innate Pharma Technical Analysis
The technical analysis module can be used to analyzes prices, returns, volume, basic money flow, and other market information and help investors to determine the real value of Innate Pharma on a daily or weekly bases. We use both bottom-up as well as top-down valuation methodologies to arrive at the intrinsic value of Innate Pharma based on its technical analysis. In general, a bottom-up approach, as applied to this company, focuses on Innate Pharma price pattern first instead of the macroeconomic environment surrounding Innate Pharma. By analyzing Innate Pharma's financials, daily price indicators, and related drivers such as dividends, momentum ratios, and various types of growth rates, we attempt to find the most accurate representation of Innate Pharma's intrinsic value. As compared to a bottom-up approach, our top-down model examines the macroeconomic factors that affect the industry/economy before zooming in to Innate Pharma specific price patterns or momentum indicators. Please read more on our technical analysis page.
Innate Pharma February 12, 2026 Technical Indicators
Most technical analysis of Innate help investors determine whether a current trend will continue and, if not, when it will shift. We provide a combination of tools to recognize potential entry and exit points for Innate from various momentum indicators to cycle indicators. When you analyze Innate charts, please remember that the event formation may indicate an entry point for a short seller, and look at different other indicators across different periods to confirm that a breakdown or reversion is likely to occur.
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | 0.0643 | |||
| Market Risk Adjusted Performance | (0.40) | |||
| Mean Deviation | 0.3771 | |||
| Coefficient Of Variation | 1339.58 | |||
| Standard Deviation | 1.63 | |||
| Variance | 2.67 | |||
| Information Ratio | 0.0113 | |||
| Jensen Alpha | 0.1375 | |||
| Total Risk Alpha | (0.08) | |||
| Treynor Ratio | (0.41) | |||
| Maximum Drawdown | 12.57 | |||
| Skewness | 6.76 | |||
| Kurtosis | 54.45 |
Innate Pharma February 12, 2026 Daily Trend Indicators
Traders often use several different daily volumes and price technical indicators to supplement a more traditional technical analysis when analyzing securities such as Innate stock. With literally thousands of different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.
| Accumulation Distribution | 0.00 | ||
| Daily Balance Of Power | 0.00 | ||
| Rate Of Daily Change | 1.00 | ||
| Day Median Price | 2.15 | ||
| Day Typical Price | 2.15 | ||
| Price Action Indicator | 0.00 |
Complementary Tools for Innate Pink Sheet analysis
When running Innate Pharma's price analysis, check to measure Innate Pharma's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Innate Pharma is operating at the current time. Most of Innate Pharma's value examination focuses on studying past and present price action to predict the probability of Innate Pharma's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Innate Pharma's price. Additionally, you may evaluate how the addition of Innate Pharma to your portfolios can decrease your overall portfolio volatility.
| Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
| Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas |